CG
APLS

Cutler Group’s Apellis Pharmaceuticals APLS Stock Holding History

Cutler Group’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,201
Closed -$650K – 2255
2023
Q4 		$610K Sell
10,201
-26,921
-73% -$1.37M 0.05% 361
2023
Q3 		$1.41M Buy
37,122
+36,343
+4,665% +$1.6M 0.14% 163
2023
Q2 		$70K Sell
779
-2,721
-78% -$235K 0.01% 1114
2023
Q1 		$230K Buy
3,500
+3,225
+1,173% +$186K 0.02% 623
2022
Q4 		$14K Buy
275
+175
+175% +$9.28K ﹤0.01% 2454
2022
Q3 		$6K Sell
100
-10,363
-99% -$613K ﹤0.01% 3454
2022
Q2 		$473K Buy
10,463
+8,200
+362% +$374K 0.03% 550
2022
Q1 		$114K Sell
2,263
-3,030
-57% -$134K 0.01% 1597
2021
Q4 		$250K Sell
5,293
-96,492
-95% -$3.8M 0.01% 1152
2021
Q3 		$3.35M Buy
101,785
+98,985
+3,535% +$5.56M 0.15% 147
2021
Q2 		$176K Buy
2,800
+2,000
+250% +$103K 0.01% 1430
2021
Q1 		$34K Buy
800
+500
+167% +$23.7K ﹤0.01% 2724
2020
Q4 		$17K Buy
+300
New +$12.7K ﹤0.01% 2781
2020
Q3 		– Sell
-2,000
Closed -$59.8K – 4622
2020
Q2 		$65K Sell
2,000
-3,800
-66% -$122K ﹤0.01% 1579
2020
Q1 		$155K Buy
+5,800
New +$206K 0.01% 1096
2019
Q4 		– Sell
-2,800
Closed -$77.5K – 3942
2019
Q3 		$67K Buy
+2,800
New +$77.1K 0.01% 1327

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's APLS Position: Q1 2024 in Review

Cutler Group sold out of Apellis Pharmaceuticals (APLS) in Q1 2024, closing a stake of 10,201 shares — an estimated $650K sold.

Cutler Group first reported a position in APLS in Q3 2019 and held it in 16 quarters. The position peaked at $3.35M in Q3 2021. 302 funds tracked by Wall St. Rank hold APLS as of Q1 2024.

  • Cutler Group reported no remaining Apellis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 10,201 Apellis Pharmaceuticals shares in Q1 2024, an estimated $650K.
  • Cutler Group first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 16 quarters.
  • Cutler Group's Apellis Pharmaceuticals position peaked at $3.35M in Q3 2021.
  • 302 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.